Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VACDITE versus IMOVAX D.T. ADULT booster vaccination trial in healthy adults
2018-001604-10Phase 4Completed
- Sponsor
- BioDrug
- Start
- Jul 2018
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tetanus and diphtheria toxoids adsorbed in Tetanus and diphtheria (2 arms), sponsored by BioDrug. Primary endpoints: Seroconversion rate for tetanus and/or diphtheria and Antibody concentration against tetanus and/or diphtheria. Started Jul 2018; status: completed.
02
Drugs
tetanus and diphtheria toxoids adsorbed
03
Conditions
Tetanusdiphtheria
Beyond the preview
Go deeper on 2018-001604-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001604-10.